Out of the loop: Augmenting diuresis with SGLT2 inhibitors in HF
Healio.com,
SGLT2 inhibitors were first approved in 2013 for the treatment of type 2 diabetes.
SGLT2 inhibitors were first approved in 2013 for the treatment of type 2 diabetes.
NEW ORLEANS — Patients with type 2 diabetes who received dapagliflozin ( Farxiga/Forxiga, AstraZeneca) in the DECLARE-TIMI 58…
Heart failure benefits with dapagliflozin (Farxiga) for patients with type 2 diabetes are greatest with patients with prior…
Heart failure benefits with dapagliflozin (Farxiga) for patients with type 2 diabetes are greatest with patients with prior…